These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 27318396)
1. Estimating eligibility for lung cancer screening in an Australian cohort, including the effect of spirometry. Manners D; Hui J; Hunter M; James A; Knuiman MW; McWilliams A; Mulrennan S; Musk AW; Brims FJ Med J Aust; 2016 Jun; 204(11):406. PubMed ID: 27318396 [TBL] [Abstract][Full Text] [Related]
2. Addressing Sex Disparities in Lung Cancer Screening Eligibility: USPSTF vs PLCOm2012 Criteria. Pasquinelli MM; Tammemägi MC; Kovitz KL; Durham ML; Deliu Z; Guzman A; Rygalski K; Liu L; Koshy M; Finn P; Feldman LE Chest; 2022 Jan; 161(1):248-256. PubMed ID: 34252436 [TBL] [Abstract][Full Text] [Related]
3. Risk Prediction Model Versus United States Preventive Services Task Force Lung Cancer Screening Eligibility Criteria: Reducing Race Disparities. Pasquinelli MM; Tammemägi MC; Kovitz KL; Durham ML; Deliu Z; Rygalski K; Liu L; Koshy M; Finn P; Feldman LE J Thorac Oncol; 2020 Nov; 15(11):1738-1747. PubMed ID: 32822843 [TBL] [Abstract][Full Text] [Related]
4. Low rates of eligibility for lung cancer screening in patients undergoing computed tomography coronary angiography. Lyne C; Zaw S; King B; See K; Manners D; Al-Kaisey A; Joshi S; Farouque O; Irving L; Johnson D; Steinfort D Intern Med J; 2018 Oct; 48(10):1265-1268. PubMed ID: 30288901 [TBL] [Abstract][Full Text] [Related]
5. Spirometry performed as part of the Manchester community-based lung cancer screening programme detects a high prevalence of airflow obstruction in individuals without a prior diagnosis of COPD. Balata H; Harvey J; Barber PV; Colligan D; Duerden R; Elton P; Evison M; Greaves M; Howells J; Irion K; Karunaratne D; Mellor S; Newton T; Sawyer R; Sharman A; Smith E; Taylor B; Taylor S; Tonge J; Walsham A; Whittaker J; Vestbo J; Booton R; Crosbie PA Thorax; 2020 Aug; 75(8):655-660. PubMed ID: 32444437 [TBL] [Abstract][Full Text] [Related]
6. Identifying high risk individuals for targeted lung cancer screening: Independent validation of the PLCO Weber M; Yap S; Goldsbury D; Manners D; Tammemagi M; Marshall H; Brims F; McWilliams A; Fong K; Kang YJ; Caruana M; Banks E; Canfell K Int J Cancer; 2017 Jul; 141(2):242-253. PubMed ID: 28249359 [TBL] [Abstract][Full Text] [Related]
7. USPSTF2013 versus PLCOm2012 lung cancer screening eligibility criteria (International Lung Screening Trial): interim analysis of a prospective cohort study. Tammemägi MC; Ruparel M; Tremblay A; Myers R; Mayo J; Yee J; Atkar-Khattra S; Yuan R; Cressman S; English J; Bedard E; MacEachern P; Burrowes P; Quaife SL; Marshall H; Yang I; Bowman R; Passmore L; McWilliams A; Brims F; Lim KP; Mo L; Melsom S; Saffar B; Teh M; Sheehan R; Kuok Y; Manser R; Irving L; Steinfort D; McCusker M; Pascoe D; Fogarty P; Stone E; Lam DCL; Ng MY; Vardhanabhuti V; Berg CD; Hung RJ; Janes SM; Fong K; Lam S Lancet Oncol; 2022 Jan; 23(1):138-148. PubMed ID: 34902336 [TBL] [Abstract][Full Text] [Related]
8. Sensitivity of US Preventive Services Task Force and PLCOm2012 lung cancer screening eligibility criteria in individuals with lung cancer in South Dakota self-reporting as Indigenous and non-Indigenous. Tammemägi MC; Cina K; Kitts AKB; Koop D; Petereit MA; Sargent M; Petereit DG Cancer; 2023 Dec; 129(24):3894-3904. PubMed ID: 37807694 [TBL] [Abstract][Full Text] [Related]
9. Risk prediction models versus simplified selection criteria to determine eligibility for lung cancer screening: an analysis of German federal-wide survey and incidence data. Hüsing A; Kaaks R Eur J Epidemiol; 2020 Oct; 35(10):899-912. PubMed ID: 32594286 [TBL] [Abstract][Full Text] [Related]
10. Comparison Between the 2021 USPSTF Lung Cancer Screening Criteria and Other Lung Cancer Screening Criteria for Racial Disparity in Eligibility. Pu CY; Lusk CM; Neslund-Dudas C; Gadgeel S; Soubani AO; Schwartz AG JAMA Oncol; 2022 Mar; 8(3):374-382. PubMed ID: 35024781 [TBL] [Abstract][Full Text] [Related]
11. Detection of COPD in the SUMMIT Study lung cancer screening cohort using symptoms and spirometry. Tisi S; Dickson JL; Horst C; Quaife SL; Hall H; Verghese P; Gyertson K; Bowyer V; Levermore C; Mullin AM; Teague J; Farrelly L; Nair A; Devaraj A; Hackshaw A; ; Hurst JR; Janes SM Eur Respir J; 2022 Dec; 60(6):. PubMed ID: 35896207 [TBL] [Abstract][Full Text] [Related]
12. Assessment of Uptake Appropriateness of Computed Tomography for Lung Cancer Screening According to Patients Meeting Eligibility Criteria of the US Preventive Services Task Force. Liu Y; Pan IE; Tak HJ; Vlahos I; Volk R; Shih YT JAMA Netw Open; 2022 Nov; 5(11):e2243163. PubMed ID: 36409492 [TBL] [Abstract][Full Text] [Related]
13. Stratification and management of patients ineligible for lung cancer screening. Aggarwal R; Lam AC; Huang J; Hueniken K; Nguyen D; Khan K; Shaikh T; Shepherd FA; Tsao MS; Xu W; Kavanagh J; Liu G Respir Med; 2021 Nov; 188():106610. PubMed ID: 34592536 [TBL] [Abstract][Full Text] [Related]
14. Prediction of Lung Cancer Screening Eligibility Using Simplified Criteria. Triplette M; Donovan LM; Crothers K; Madtes DK; Au DH Ann Am Thorac Soc; 2019 Oct; 16(10):1280-1285. PubMed ID: 31298946 [No Abstract] [Full Text] [Related]
15. Potential Disparities by Sex and Race or Ethnicity in Lung Cancer Screening Eligibility Rates. Pinsky PF; Lau YK; Doubeni CA Chest; 2021 Jul; 160(1):341-350. PubMed ID: 33545164 [TBL] [Abstract][Full Text] [Related]
16. Persistent race- and sex-based disparities in lung cancer screening eligibility. Potter AL; Senthil P; Srinivasan D; Raman V; Kumar A; Haridas C; Mathey-Andrews C; Zheng W; Jeffrey Yang CF J Thorac Cardiovasc Surg; 2024 Jul; 168(1):248-260.e2. PubMed ID: 37863179 [TBL] [Abstract][Full Text] [Related]
17. Tobacco use and motivation to stop smoking among long-term smokers who are ineligible for lung cancer screening. Taghizadeh N; Taylor KL; MacEachern P; Koetzler R; Dickinson JA; Gillson A; Yang H; Tammemagi MC; Penz E; Pendharkar SR; Lam SC; Graham A; Culling J; Burrowes P; Bédard ELR; Tremblay A Lung Cancer; 2017 Sep; 111():101-107. PubMed ID: 28838378 [TBL] [Abstract][Full Text] [Related]
18. Identifying high-risk individuals for lung cancer screening: Going beyond NLST criteria. Fu M; Travier N; Martín-Sánchez JC; Martínez-Sánchez JM; Vidal C; Garcia M; PLoS One; 2018; 13(4):e0195441. PubMed ID: 29621354 [TBL] [Abstract][Full Text] [Related]
19. A Comparative Modeling Analysis of Risk-Based Lung Cancer Screening Strategies. Ten Haaf K; Bastani M; Cao P; Jeon J; Toumazis I; Han SS; Plevritis SK; Blom EF; Kong CY; Tammemägi MC; Feuer EJ; Meza R; de Koning HJ J Natl Cancer Inst; 2020 May; 112(5):466-479. PubMed ID: 31566216 [TBL] [Abstract][Full Text] [Related]
20. Race & sex disparities related to low-dose computed tomography lung cancer screening eligibility criteria: A lung cancer cases review. Williams RM; Kareff SA; Sackstein P; Roy T; Luta G; Kim C; Taylor KL; Tammemägi MC Lung Cancer; 2022 Jul; 169():55-60. PubMed ID: 35644087 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]